Publications by authors named "Jiang-Shui Ding"
Introduction: Providing precise oncologic treatment for patients with refractory solid tumor is still an unmet need in clinical practice. This study aimed to assess whether treatments recommended by a molecular tumor board (MTB) can improve clinical outcomes in patients with refractory solid tumors.
Methods: We screened all patients with refractory solid tumor during the period from 2017 to 2022 at the authors' center.